HNGE, founded in 2012, is a company that primarily operates in the healthcare sector, focusing on musculoskeletal (MSK) treatments. The company generates revenue through subscriptions sold to clients in the United States, leveraging AI and machine learning technologies to enhance its platform and services. HNGE's business activities include maintaining and increasing its client base, expanding into new markets, and complying with healthcare regulations.
- Subscription Services - Offers subscription-based access to MSK treatment programs for clients in the United States.
- Enso Device - Provides a device subject to government regulation, used in MSK treatments, with a focus on compliance with healthcare laws and regulations.
You might also like
Research analysts who have asked questions during Hinge Health earnings calls.
Bradley Sills
Bank of America
1 question for HNGE
Brian Peterson
Raymond James Financial
1 question for HNGE
Craig Hettenbach
Morgan Stanley
1 question for HNGE
Elizabeth Anderson
Evercore ISI
1 question for HNGE
Jailendra Singh
Truist Securities
1 question for HNGE
Richard Close
Canaccord Genuity Group
1 question for HNGE
Ryan Daniels
William Blair & Company, L.L.C.
1 question for HNGE
Saket Kalia
Barclays Capital
1 question for HNGE
No recent press releases or 8-K filings found for HNGE.